Worth reading
46Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
Applicable field (uses covered by this announcement)
Sales and logistics structure
Launch date1 April 2026 (Wednesday) (stated as the date operations will begin, not as a planned date)
Relationship between the counterparty and the company
SUZUKEN CO.,LTD.9987
Relationship with the Company
株式会社翔薬 is a consolidated subsidiary of the Company.
Counterparty (name not disclosed)
株式会社翔薬. It is stated to be a consolidated subsidiary. Other information on its location, representative, business activities, capital, and year of establishment is Not disclosed.
Location (as indicated in this announcement)
〒851-0134 587-2 Tanaka-machi, Nagasaki, Nagasaki (Nagasaki Branch)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Counterparty overview | 株式会社翔薬. It is stated to be a consolidated subsidiary. Other information on its location, representative, business activities, capital, and year of establishment is Not disclosed. |
| Relationship with the Company | 株式会社翔薬 is a consolidated subsidiary of the Company. |
| Launch date | 1 April 2026 (Wednesday) (stated as the date operations will begin, not as a planned date) |
| Applicable area | Sales and logistics structure |
| Location | 〒851-0134 587-2 Tanaka-machi, Nagasaki, Nagasaki (Nagasaki Branch) |
Items this document does not state (13)
Names of Products / Services CoveredCounterpartyContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As part of efforts to establish an optimal sales and logistics structure.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.